Skip to content

Clinical trials

Neoplasms by Site trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Clear all

207 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20031
20061
20073
20083
200910
20107
201116
20127
20138
201411
20156
20168
201710
201810
201913
202010
202115
20229
202320
202410
202516
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Recruiting49
Terminated33
Unknown status24
Active, not recruiting22
Withdrawn4
No longer available2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Cancer Research UK7
Exact Sciences Corporation6
Revolution Medicines, Inc.6
Steba Biotech S.A.6
Eli Lilly and Company5
Blueprint Medicines Corporation4
Hoffmann-La Roche4
Sumitomo Pharma America, Inc.4
Boston Scientific Corporation3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site207
Neoplasms183
Carcinoma55
Neoplasms by Histologic Type54
Digestive System Neoplasms52
Digestive System Diseases49
Lung Neoplasms46
Urogenital Neoplasms44
Carcinoma, Non-Small-Cell Lung42
Gastrointestinal Neoplasms41

Trials

Showing 26 to 50 of 207. Each trial links to its page on Pharma Observatory.

107 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.